Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126951351 | 12695135 | 1 | I | 20160820 | 20160829 | 20160829 | EXP | SA-MYLANLABS-2016M1036386 | MYLAN | ALSHUKAIRI AN, ALRAJHI AA, ALAMRI AW, ALOTHMAN AF. SUCCESSFUL TREATMENT OF MULTI-FOCAL XDR TUBERCULOUS OSTEOMYELITIS. J-INFECT-PUB-HEALTH 2016;9(4):408-414. | 0.00 | Y | 0.00000 | 20160829 | OT | SA | SA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126951351 | 12695135 | 1 | PS | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | Unknown | U | 65195 | ||||||||||
| 126951351 | 12695135 | 2 | SS | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | Unknown | U | 65195 | ||||||||||
| 126951351 | 12695135 | 3 | SS | LINEZOLID. | LINEZOLID | 1 | Unknown | U | 0 | ||||||||||
| 126951351 | 12695135 | 4 | SS | LINEZOLID. | LINEZOLID | 1 | Unknown | U | 0 | ||||||||||
| 126951351 | 12695135 | 5 | SS | AMPICILLIN TRIHYDRATE W/CLAVULANATE POTASSIUM | AMPICILLIN TRIHYDRATECLAVULANATE POTASSIUM | 1 | Unknown | U | 0 | ||||||||||
| 126951351 | 12695135 | 6 | SS | AMPICILLIN TRIHYDRATE W/CLAVULANATE POTASSIUM | AMPICILLIN TRIHYDRATECLAVULANATE POTASSIUM | 1 | Unknown | U | 0 | ||||||||||
| 126951351 | 12695135 | 7 | SS | MEROPENEM. | MEROPENEM | 1 | Unknown | U | 0 | ||||||||||
| 126951351 | 12695135 | 8 | SS | MEROPENEM. | MEROPENEM | 1 | Unknown | U | 0 | ||||||||||
| 126951351 | 12695135 | 9 | C | CLOFAZIMINE | CLOFAZIMINE | 1 | Unknown | FOR 4, 2 AND 18 MONTHS | U | 0 | |||||||||
| 126951351 | 12695135 | 10 | C | CLOFAZIMINE | CLOFAZIMINE | 1 | Unknown | FOR 4, 2 AND 18 MONTHS | U | 0 | |||||||||
| 126951351 | 12695135 | 11 | C | CYCLOSERINE. | CYCLOSERINE | 1 | Unknown | FOR 4, 2 AND 18 MONTHS | U | 0 | |||||||||
| 126951351 | 12695135 | 12 | C | CYCLOSERINE. | CYCLOSERINE | 1 | Unknown | FOR 4, 2 AND 18 MONTHS | U | 0 | |||||||||
| 126951351 | 12695135 | 13 | C | AMINOSALICYLIC ACID | AMINOSALICYLIC ACID | 1 | Unknown | FOR 4, 2 AND 18 MONTHS | U | 0 | |||||||||
| 126951351 | 12695135 | 14 | C | AMINOSALICYLIC ACID | AMINOSALICYLIC ACID | 1 | Unknown | FOR 4, 2 AND 18 MONTHS | U | 0 | |||||||||
| 126951351 | 12695135 | 15 | C | CAPREOMYCIN | CAPREOMYCIN | 1 | Unknown | DAILY | U | 0 | |||||||||
| 126951351 | 12695135 | 16 | C | CAPREOMYCIN | CAPREOMYCIN | 1 | Unknown | DAILY | U | 0 | |||||||||
| 126951351 | 12695135 | 17 | C | MOXIFLOXACIN. | MOXIFLOXACIN | 1 | Unknown | FOR 4, 2 AND 18 MONTHS | U | 0 | |||||||||
| 126951351 | 12695135 | 18 | C | MOXIFLOXACIN. | MOXIFLOXACIN | 1 | Unknown | FOR 4, 2 AND 18 MONTHS | U | 0 | |||||||||
| 126951351 | 12695135 | 19 | C | AMIKACIN | AMIKACIN | 1 | Unknown | EVERY OTHER DAY | U | 0 | |||||||||
| 126951351 | 12695135 | 20 | C | AMIKACIN | AMIKACIN | 1 | Unknown | EVERY OTHER DAY | U | 0 | |||||||||
| 126951351 | 12695135 | 21 | C | AZITHROMYCIN ANHYDROUS. | AZITHROMYCIN ANHYDROUS | 1 | Unknown | U | 0 | ||||||||||
| 126951351 | 12695135 | 22 | C | AZITHROMYCIN ANHYDROUS. | AZITHROMYCIN ANHYDROUS | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126951351 | 12695135 | 1 | Bone tuberculosis |
| 126951351 | 12695135 | 2 | Tuberculosis |
| 126951351 | 12695135 | 3 | Tuberculosis |
| 126951351 | 12695135 | 4 | Bone tuberculosis |
| 126951351 | 12695135 | 5 | Bone tuberculosis |
| 126951351 | 12695135 | 6 | Tuberculosis |
| 126951351 | 12695135 | 7 | Bone tuberculosis |
| 126951351 | 12695135 | 8 | Tuberculosis |
| 126951351 | 12695135 | 9 | Bone tuberculosis |
| 126951351 | 12695135 | 10 | Tuberculosis |
| 126951351 | 12695135 | 11 | Bone tuberculosis |
| 126951351 | 12695135 | 12 | Tuberculosis |
| 126951351 | 12695135 | 13 | Bone tuberculosis |
| 126951351 | 12695135 | 14 | Tuberculosis |
| 126951351 | 12695135 | 15 | Bone tuberculosis |
| 126951351 | 12695135 | 16 | Tuberculosis |
| 126951351 | 12695135 | 17 | Bone tuberculosis |
| 126951351 | 12695135 | 18 | Tuberculosis |
| 126951351 | 12695135 | 19 | Bone tuberculosis |
| 126951351 | 12695135 | 20 | Tuberculosis |
| 126951351 | 12695135 | 21 | Bone tuberculosis |
| 126951351 | 12695135 | 22 | Tuberculosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126951351 | 12695135 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126951351 | 12695135 | Abdominal discomfort | |
| 126951351 | 12695135 | Axonal neuropathy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |